It's a valid point and I respect your input. It's true that in 99% of cases the manufacturer/brand owner has little or no bargaining power with the Coles/woolies duopoly. The big two supermarkets have abused this power to the benefit of their own shareholders (is that wrong? Or is it free market capitalism?).
There is only one exception as far as I can see, and it's Infant formula. Why? The answer was in the recent strategy deck released to the market. Please tell me any other supermarket category where total category sales increased 50+% in the last year and has total sales over $500 million?
BAL is not paying for these additional facings or gondola ends, it's is simply the supermarkets maximising sales in a rapidly growing and highly profitable category. IF category leaders, so Aptamil (Danone), Bellamys and A2 have power in this situation, it is one of the few categories where home brand products don't work and Coles/woolies are price takers.
The proof of what I'm proposing is evident in the Nov price rise on BAL stage 3. Please tell me any other product on supermarket shelves that put through a 30%+ price rise in the last 5 years??
We do have visability on what BAL does to sell its products, an average of 4% in trading rebates... 4% is on the very low side of such things as I'm sure you are aware.
- Forums
- ASX - By Stock
- BAL
- stock
stock, page-569
-
-
- There are more pages in this discussion • 729 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online